Stock ALBANY MOLECULAR RESEARCH, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Albany Molecular Research, Inc. Stock

Equities

US0124231095

Biotechnology & Medical Research

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Chart Albany Molecular Research, Inc.

Dynamic Chart

Press releases Albany Molecular Research, Inc.

Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes... PU
Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer PU
Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen... PU
Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity PU
Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting PU
More press releases

News in other languages on Albany Molecular Research, Inc.

Albany Molecular Research, Inc. : AMRI annonce un accord de collaboration avec Lilly pour des services internalisés dans le domaine de la chimie
ALBANY MOLE RES : AMRI fait l'acquisition d'Excelsyn Ltd.
ALBANY MOLECULAR R COM USD0.01 : AMRI ouvre un nouveau centre de recherche à Budapest en Hongrie
Albany Molecular Res : AMRI a nommé un nouveau directeur pour son secteur chimie de son site européen
Albany Molecular Res : ComGenex est rebaptisé AMRI Hungary ; une gamme complète de services AMRI est désormais disponible pour les clients de ComGenex
More news

Managers and Directors - Albany Molecular Research, Inc.

Managers TitleAgeSince
Philip W Macnabb CEO
 Chief Executive Officer - 23-04-30
Meera Khullar CMP
 Compliance Officer - 19-02-28
Prakash Pandian CTO
 Chief Tech/Sci/R&D Officer - 18-05-31
Members of the board TitleAgeSince
Dean Mihas BRD
 Director/Board Member 57 -
Sean Cunningham BRD
 Director/Board Member 48 -
William McMullan BRD
 Director/Board Member 46 -
More insiders

Company Profile

More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+24.89% 46.71B
LONZA GROUP AG Stock Lonza Group AG
+48.83% 41.8B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.05% 41.52B
CELLTRION, INC. Stock Celltrion, Inc.
-5.86% 29.55B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+10.31% 25.78B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.87% 19.26B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+1.82% 12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.30% 12.08B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.42% 11.98B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW